Insider Selling Surge: Disc Medicine’s Key Shareholder Dumps 30K Shares Amid Bullish Rally, Raising Liquidity Concerns for Investors
Insider Kevin Bitterman’s recent bulk sales of Disc Medicine shares, amid a sharp price rebound after a Phase‑3 trial success, highlight tactical liquidity moves and potential short‑squeeze risks for investors.
3 minutes to read